Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.12 - $63.20
Previous CloseN/A
Volume92.25K
Average Volume (3M)323.82K
Market Cap
$1.57B
Enterprise Value$1.49B
Total Cash (Recent Filing)$288.45M
Total Debt (Recent Filing)$46.54M
Price to Earnings (P/E)34.9
Beta1.12
Next Earnings
May 08, 2025EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.90
Shares Outstanding50,119,700
10 Day Avg. Volume292,174
30 Day Avg. Volume323,821
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)N/A
Price to Sales (P/S)0.85
Price to Cash Flow (P/CF)-39.70
P/FCF Ratio9.50
Enterprise Value/Market Cap0.95
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.50
Enterprise Value/Ebitda10.53
Forecast
1Y Price Target
$48.13Price Target Upside57.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
---
Astrana Health News
PremiumCompany Announcements
Astrana Health Appoints New Chief Accounting Officer
PremiumCompany Announcements
Astrana Health Highlights Strategic Acquisition Plans
PremiumCompany Announcements
Astrana Health Updates Corporate Presentation for Conferences---
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactAdding Prospect Health deepens Astrana Health's competitive edge in Southern California as a scaled entry point to a competitive Orange County.
Strategic InvestmentsThe proposed G&A investments are seen as logical steps to improve future efficiencies, indicating a strategic approach to growth.
Valuation OpportunityThe valuation of Astrana Health Inc. presents a potentially unique opportunity for investors, highlighting a long-term view.
Bears Say
Earnings ExpectationsManagement's initial full year 2025 adjusted EBITDA guidance is below consensus, coming in at $180 million at the midpoint.
Execution And Integration RisksThe price target for Astrana Health Inc. has been lowered to $40 to reflect elevated execution and integration risk.
Medicaid RiskMedicaid risk is perceived as misunderstood, with potential financial impacts that could affect earnings.
---
Ownership Overview
47.19% Insiders
15.44% Mutual Funds
0.20% Other Institutional Investors
15.38% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ASTH FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was $23.12 and its highest was $63.20 in the past 12 months.
What is Astrana Health’s market cap?
Astrana Health’s market cap is $1.57B.
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is May 08, 2025 which is in 11 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Feb 27, 2025. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of $0.099 by -$0.249.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is 0.21.
How many shares outstanding does Astrana Health have?
Astrana Health has 50,119,700 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of -$0.15 in its last earnings report, missing expectations of $0.099. Following the earnings report the stock price went down -26.817%.
Which hedge fund is a major shareholder of Astrana Health?
Currently, no hedge funds are holding shares in ASTH
---
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$48.13 (57.29% Upside)
$48.13 (57.29% Upside)
Hedge Fund Trend
Increased
By 45.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 2.3%
Last 30 Days ▼ 7.0%
Last 30 Days ▼ 7.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.15%
12-Months-Change
Fundamentals
Return on Equity
6.50%
Trailing 12-Months
Asset Growth
43.96%
Trailing 12-Months
Company Description
Astrana Health
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
---
ASTH Company Deck
---
ASTH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Astrana Health showed strong revenue growth and strategic expansion through acquisitions, but faced challenges due to strategic investment costs, Medicaid utilization headwinds, and high integration costs relating to acquisitions.Read More>---
ASTH Stock 12 Month Forecast
Average Price Target
$48.13
▲(57.29% Upside)
Technical Analysis
Addus Homecare
―
Pediatrix Medical Group
―
National Healthcare
―
Agilon Health
―
Ardent Health Partners, Inc.
―
Best Analysts Covering ASTH
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
+11.35%
reiterated a buy rating 7 months ago
Copying David Larsen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.35% per trade.
---